| MSU | maple sugar urine; maple syrup urine; medical studies unit; mid-stream urine; monosodium urate; myoc... |
|---|---|
| NIHS | National Institute of Hypertension Studies |
| RRN | returning [for advanced studies] registered nurse |
| SNCS | sensory nerve conduction studies |
| SOLVD | studies of left ventricular dysfunction |
| tetanus neonatorum | Tetanus occurring in newborn infants, usually due to infection of umbilical area with Clostridium tetani, often a result of ritualistic practices; has high fatality rate (about 60%). Synonym: neonatal tetanus. (05 Mar 2000) |
|---|---|
| encephalitis neonatorum | Encephalitis of the newborn, described by R. Virchow as marked by the presence of fat-laden cells in the brain. (05 Mar 2000) |
| trismus neonatorum | Stiffness of the jaw muscles in neonates, usually as the beginning of tetanus neonatorum. Synonym: trismus neonatorum. (05 Mar 2000) |
| erythema neonatorum | A common transient idiopathic eruption of erythema, small papules, and occasionally pustules filled with eosinophilic leukocytes overlying hair follicles of the newborn. Synonym: erythema neonatorum. (05 Mar 2000) |
| erythema toxicum neonatorum | A common transient idiopathic eruption of erythema, small papules, and occasionally pustules filled with eosinophilic leukocytes overlying hair follicles of the newborn. Synonym: erythema neonatorum. (05 Mar 2000) |
| retrospective studies | Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. (12 Dec 1998) |
| pharmalogical studies | <pharmacology> Studies to assess the potential harmful or other effects of drugs (16 Dec 1997) |
| clinical studies | <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product. (14 Nov 1997) |
| cohort studies | Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. (12 Dec 1998) |
| combination studies | <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs. (09 Jan 1998) |
| multicenter studies | Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. (12 Dec 1998) |
| multivariate studies | The use of statistical techniques for the simultaneous investigations of the influence of several variables. (05 Mar 2000) |
| preclinical studies | <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application. (14 Nov 1997) |
| sampling studies | Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled. (12 Dec 1998) |
| prospective studies | Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. (12 Dec 1998) |